#002 — 1.62% (20.25MG/1.25GM PACKET) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
RLDAB2
8 patents0 exclusivities▾
GEL;TRANSDERMAL | Approved: Sep 7, 2012
#003 — 1.62% (40.5MG/2.5GM PACKET) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**